Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 7/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3888518 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL305260 | 1.00 | — | — | |
| SCHEMBL10533402 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL4514650 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL7043940 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL305184 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL153016 | 1.00 | — | — | |
| SCHEMBL2145601 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL22688944 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL31404556 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 758 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4688736-A1 | IMPROVED PROCESS FOR THE PRODUCTION OF AN ASTAXANTHIN INTERMEDIATE | DSM IP Assets B.V. (NL) | 2026-02-11 | — | — | EP | claimed |
| WO-2025242747-A1 | MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS | MERCK PATENT GMBH (DE) | 2025-11-27 | — | — | WO | claimed |
| CN-118772194-A | Alkyl germanium compound, preparation method and application | 宝鸡文理学院 | 2024-10-15 | — | — | CN | claimed |
| WO-2024200695-A1 | IMPROVED PROCESS FOR THE PRODUCTION OF AN ASTAXANTHIN INTERMEDIATE | DSM IP ASSETS B.V. (NL) | 2024-10-03 | — | — | WO | claimed |
| CN-115594571-A | Preparation method of single-chain alkyl keto acid vesicle | 河南中医药大学（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-114044753-A | Small molecular compound with anti-tumor metastasis function and preparation method thereof | 广州市朝利良生物科技有限公司 | 2022-02-15 | — | — | CN | claimed |
| CN-111978154-A | Preparation method of 4-octyl phenethyl alcohol | 南京康德祥医药科技有限公司 | 2020-11-24 | — | — | CN | claimed |
| CN-109970534-B | Method for synthesizing peach fruit moth sex pheromone | 中国农业大学 | 2020-11-13 | — | — | CN | claimed |
| CN-109970534-A | A method of synthesis sex pheromone of Carposina niponensis | 中国农业大学 | 2019-07-05 | — | — | CN | claimed |
| CN-106349164-A | Imidazolyl Ionic liquids preparing method | 江苏康乐新材料科技有限公司 | 2017-01-25 | — | — | CN | claimed |
| CN-103917522-B | Process for producing N- (hetero) arylazoles | 高砂香料工业株式会社 | 2016-06-15 | — | — | CN | claimed |
| US-9233922-B2 | Process for producing N-(hetero)arylazoles | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-01-12 | — | — | US | claimed |
| US-7704468-B1 | Method for forming an extraction agent for the separation of actinides from lanthanides | BATTELLE ENERGY ALLIANCE, LLC (US) | 2010-04-27 | — | — | US | claimed |
| US-20100094042-A1 | METHOD FOR FORMING AN EXTRACTION AGENT FOR THE SEPARATION OF ACTINIDES FROM LANTHANIDES | BATTELLE ENERGY ALLIANCE, LLC | 2010-04-15 | — | — | US | claimed |
| US-7273948-B2 | Process of preparing esters and ethers of probucol and derivatives thereof | ATHEROGENICS, INC. (US) | 2007-09-25 | — | — | US | claimed |
| WO-2007037995-A2 | EXTRACTION AGENT AND METHOD FOR FORMING AN EXTRACTION AGENT FOR THE SEPARATION OF ACTINIDES FROM LANTHANIDES | BATTELLE ENERGY ALLIANCE, LLC (US) | 2007-04-05 | — | — | WO | claimed |
| EP-1594824-A4 | PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF | ATHEROGENICS INC (US) | 2007-04-04 | — | — | EP | claimed |
| EP-1594824-A2 | PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF | Atherogenics, Inc. (US) | 2005-11-16 | — | — | EP | claimed |
| US-20040204485-A1 | Process of preparing esters and ethers of probucol and derivatives thereof | CRABTREE ACQUISITION CO, LLC | 2004-10-14 | — | — | US | claimed |
| WO-2004062622-A2 | PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF | ATHEROGENICS, INC. (US) | 2004-07-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100094042-A1 | METHOD FOR FORMING AN EXTRACTION AGENT FOR THE SEPARATION OF ACTINIDES FROM LANTHANIDES | GLA, PPIP5K2, DDOST | TSHR 795/4885THRB 1589/4885DNM1 487/4885 |
| US-20040204485-A1 | Process of preparing esters and ethers of probucol and derivatives thereof | NR3C2, MGLL, GCG | TSHR 1000/4885THRB 269/4885DNM1 3686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.